Insights

Immunogen-grade expansion Athens Bioscience recently launched an immunogen-grade protein line verified by mass spectrometry, signaling a potential upsell to customers needing higher-purity, application-specific proteins for diagnostics, assay calibration, and regulatory filings.

Regulatory-ready manufacturing With ISO 9001:2015 certified in-house production, single-site custody, and batch-to-batch consistency, target firms in regulated IVD development and clinical research who require traceable supply chains and audit-ready materials.

Native protein differentiator Offering 170+ native human and animal proteins with preserved post-translational modifications positions Athens as a supplier for labs seeking authentic protein performance for calibrators, media formulations, and reproducible research.

Backed by credibility Extensive literature support (over 2,500 peer‑reviewed citations) can be leveraged to justify procurement decisions and form co-authored validation or benchmarking studies with potential customers.

End-to-end customization The capability to deliver purity grade, formulation, and scale tailored to specifications suggests opportunities for deep, contract-based partnerships with IVD developers, cell culture media companies, and life science researchers seeking single-source protein supply.

Similar companies to Athens Bioscience, Inc.

Athens Bioscience, Inc. Tech Stack

Athens Bioscience, Inc. uses 8 technology products and services including Hotjar, Microsoft Clarity, Amazon Web Services, and more. Explore Athens Bioscience, Inc.'s tech stack below.

Athens Bioscience, Inc.'s Email Address Formats

Athens Bioscience, Inc. uses at least 1 email format:
Athens Bioscience, Inc. Email FormatsExamplePercentage
First.Last@athensresearch.comJohn.Doe@athensresearch.com
100%

Frequently Asked Questions

What is Athens Bioscience, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s official website is athensbioscience.com and has social profiles on LinkedIn.

How much revenue does Athens Bioscience, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Athens Bioscience, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Athens Bioscience, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Athens Bioscience, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Athens Bioscience, Inc. has approximately 27 employees across 3 continents, including North America, Europe and Asia. Key team members include Chairman & Chief Executive Officer: B. N., Research Director: V. P. and China Representative For Sales And Marketing: S. Z. Explore Athens Bioscience, Inc.'s employee directory with LeadIQ.

What industry does Athens Bioscience, Inc. belong to?

Minus sign iconPlus sign icon
Athens Bioscience, Inc. operates in the Biotechnology Research industry.

What technology does Athens Bioscience, Inc. use?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s tech stack includes Hotjar, Microsoft Clarity, Amazon Web Services, Cookiebot, BigCommerce, Microsoft 365, HubSpot and Vercel.

What is Athens Bioscience, Inc.'s email format?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s email format typically follows the pattern of First.Last@athensresearch.com. Find more Athens Bioscience, Inc. email formats with LeadIQ.

When was Athens Bioscience, Inc. founded?

Minus sign iconPlus sign icon
Athens Bioscience, Inc. was founded in 1986.
Athens Bioscience, Inc. logo

Athens Bioscience, Inc.

Biotechnology ResearchGeorgia, United States11-50 Employees

Athens Bioscience, Inc. is a biotechnology company based in Athens, Georgia, focused on producing native human and animal proteins for diagnostic developers, cell culture media companies, and life science researchers. Its offerings are designed to address variability in assays, media performance, and research reproducibility by providing proteins with authentic native properties and consistent quality, produced entirely in-house under ISO 9001:2015-certified processes. The company serves customers who need proteins that preserve native post-translational modifications and physiological activity, with traceable quality and a single-site manufacturing footprint to streamline regulatory qualification and audits.
Operating within the biotechnology research sector, Athens Bioscience emphasizes reliability and consistency across all sizes of production, from small research orders to commercial-scale lots, ensuring uniformity across batches and lots. The firm highlights a centralized approach to purity, formulation, and scale tailored to customer specifications, positioning itself as a manufacturing partner rather than a traditional supplier. In recent developments, the company announced the launch of an immunogen-grade protein line, underscoring an expansion of its product offerings anchored in verified purity and composition.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1986
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Athens Bioscience, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.